CN217067399U - Novel brain is dosed device - Google Patents

Novel brain is dosed device Download PDF

Info

Publication number
CN217067399U
CN217067399U CN202220139162.3U CN202220139162U CN217067399U CN 217067399 U CN217067399 U CN 217067399U CN 202220139162 U CN202220139162 U CN 202220139162U CN 217067399 U CN217067399 U CN 217067399U
Authority
CN
China
Prior art keywords
base
drug delivery
medicine
bag sleeve
tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202220139162.3U
Other languages
Chinese (zh)
Inventor
周贺芙
吴景文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Laiwo Medical Technology Co ltd
Original Assignee
Jilin Laiwo Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin Laiwo Medical Technology Co ltd filed Critical Jilin Laiwo Medical Technology Co ltd
Priority to CN202220139162.3U priority Critical patent/CN217067399U/en
Application granted granted Critical
Publication of CN217067399U publication Critical patent/CN217067399U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The utility model discloses a novel brain drug delivery device, which comprises a drug bag sleeve, a base and a transfusion tube, wherein the upper surface of the base is provided with a drug delivery cavity, the lower surface of the drug bag sleeve is provided with a drug loading cavity matched with the base, and the drug loading cavity and the drug delivery cavity form a drug bag; the side of the base is provided with an output tube, the output tube is connected with the infusion tube, the far end of the infusion tube is a blind end, and a plurality of infusion holes are formed in the circumferential surface of the far end of the infusion tube. The utility model discloses the brain device of dosing simple structure, the function is practical, has replaced the current operation of dosing of having an wound, has reduced the damage to the brain tissue, has reduced the exogenous infection risk, improves brain tissue absorption rate, has improved treatment, has shortened patient's cure time, has reduced the medical expense, has improved patient's quality of life.

Description

Novel brain is dosed device
Technical Field
The utility model relates to a brain device field of dosing especially relates to a novel brain is dosed device.
Background
Due to the presence of the blood-brain barrier, most of the material cannot reach the cranium. Even if the target substance is injected through the abdominal cavity or the blood vessel, the target substance enters the cranium through the circulation of body fluid. However, most drugs are metabolized during this process. That is, the substance that enters the cranium in this way is not the drug we originally injected, but a metabolite of the substance. Secondly, this mode of administration helps to improve the efficiency of use of drugs, particularly high value and self-extracting drugs. The quantity of the medicine injected into the abdominal cavity is higher than that of the medicine injected into the craniocerebra by dozens of times. Therefore, when the medicine is limited, the craniocerebral administration can greatly reduce the medicine loss.
Furthermore, when continuous administration is needed, the existing craniocerebral injection administration mode has low efficiency, multiple injections are needed, great psychological burden and economic burden are brought to patients, and in order to provide invasive administration, the workload of medical staff is increased by increasing infection risks, so that how to develop a novel brain administration device becomes a problem to be solved urgently by technical staff in the field.
SUMMERY OF THE UTILITY MODEL
The utility model aims at providing a novel brain is dosed device solves current craniocerebral injection mode of dosing efficiency and is lower, needs to have the wound injection many times, and the infection risk is big, brings great psychological burden and economic burden for patient, has also increased the problem of medical personnel's work load.
In order to solve the technical problem, the utility model adopts the following technical scheme:
the utility model relates to a novel brain drug delivery device, which comprises a drug bag sleeve, a base and a transfusion tube, wherein the upper surface of the base is provided with a drug delivery cavity, the lower surface of the drug bag sleeve is provided with a drug loading cavity matched with the base, and the drug loading cavity and the drug delivery cavity form a drug bag; the side of the base is provided with an output tube, the output tube is connected with the infusion tube, the far end of the infusion tube is a blind end, and a plurality of infusion holes are formed in the circumferential surface of the far end of the infusion tube.
Furthermore, the vertical section of the medicine bag sleeve is trapezoidal, and a groove is formed in the top end of the medicine bag sleeve.
Further, the medicine bag sleeve is made of medical silica gel.
Furthermore, a nylon mesh is arranged on the outer surface of the medicine bag sleeve.
Further, the base specifically adopts the polyethylene material, the output tube with base integrated into one piece.
Furthermore, the output tube is provided with a connector and is detachably connected with the near end of the infusion tube through the connector.
Further, the transfer line specifically adopts medical silica gel material.
Furthermore, the cross sections of the medicine bag sleeve and the base are circular.
Compared with the prior art, the utility model discloses a beneficial technological effect:
the utility model discloses the brain device of dosing is as a long-term device of dosing, be used for treating some refractory diseases and old disease, the anther sac that constitutes the medicine feeding chamber of anther sac cover and the lower medicine chamber of base is placed in the brain cortex through the operation, with the transfer line through the probe send to pathological change position, regularly get into the anther sac through injecting the medicine, the medicine reachs pathological change department through the transfer line, the obstructed blood brain barrier that passes through, the medicine is effectual fast, high concentration, various troubles that the repeated operation brought have also been avoided simultaneously. The utility model discloses the brain device of dosing simple structure, the function is practical, has replaced the current operation of dosing of having an wound, has reduced the damage to the brain tissue, has reduced the exogenous infection risk, improves brain tissue absorption rate, has improved treatment, has shortened patient's cure time, has reduced the medical expense, has improved patient's quality of life.
Drawings
The invention will be further described with reference to the following description of the drawings:
fig. 1 is a top view (without a grid) of the novel brain drug delivery device of the present invention;
fig. 2 is a front view (without grid) of the novel brain drug delivery device of the present invention;
FIG. 3 is a top view of the sachet sleeve;
FIG. 4 is a cross-sectional view taken along line A-A of FIG. 3;
FIG. 5 is a top view of the base;
FIG. 6 is a cross-sectional view taken along line B-B of FIG. 5;
FIG. 7 is a front view of the infusion tube;
FIG. 8 is a cross-sectional view taken at C-C of FIG. 7;
fig. 9 is a top view of the novel brain drug delivery device of the present invention;
fig. 10 is a front view of the novel brain drug delivery device of the present invention.
Description of reference numerals: 1. a medicine bag sleeve; 101. a medicine feeding cavity; 102. a groove; 2. a base; 201. a medicine feeding cavity; 202. an output pipe; 203. a connector; 3. nylon meshes; 4. a transfusion tube; 401. and (4) an infusion hole.
Detailed Description
As shown in fig. 1 to 10, a novel brain drug delivery device comprises a drug bag sleeve 1, a base 2 and a transfusion tube 4.
Medicine cavity 201 has been seted up to the upper surface of base 2, the lower surface of medicine bag cover 1 seted up with base 2 complex is gone up medicine cavity 101, it constitutes the anther sac with medicine cavity 201 down to go up medicine cavity 101. The sachet is used for storing medicaments.
The medicine bag sleeve 1 is matched with the base 2 in a clamping manner and can be further bonded.
The medicine bag sleeve 1 is made of medical silica gel materials, and a needle head of the injector can penetrate into the medicine to be supplemented conveniently.
The vertical section of the medicine bag sleeve 1 is trapezoidal, the cross section of the medicine bag sleeve 1 is circular, the top end of the medicine bag sleeve 1 is provided with a groove 102, the groove 102 facilitates positioning of a syringe needle, and demolding in the production process is facilitated.
The outer surface of the medicine bag sleeve 1 is provided with a nylon grid 3. The nylon mesh 3 can effectively prevent the drug delivery device from moving in brain tissue.
The cross section of the base 2 is circular. The side of base 2 is provided with output tube 202, base 2 specifically adopts the polyethylene material, can effectively prevent that the medicine supplementing needle from puncturing base 2 by accident, injuring the brain tissue. The outlet pipe 202 is integrally formed with the base 2.
The output tube 202 is provided with a connector 203, and the output tube 202 is detachably connected with the near end of the infusion tube 4 through the connector 203.
The far end of the infusion tube 4 is a blind end, and a plurality of infusion holes 401 are arranged on the circumferential surface of the far end of the infusion tube 4. The infusion tube 4 is made of medical silica gel.
The action process of the utility model is as follows:
1. incising the cerebral cortex, putting the assembled drug delivery device, and enabling the infusion tube 4 to reach a diseased part through a probe;
2. taking out the probe, and suturing the cerebral cortex;
3. when in administration, a needle filled with liquid medicine is used to puncture the medicine bag sleeve 1, the liquid medicine is injected into the medicine bag, the liquid medicine naturally flows into a diseased region through an infusion hole 401 of an infusion tube 4, and the scalp administration bag sleeve 1 can be used for pressurization to rapidly administer the medicine;
4. the injection of the liquid medicine is performed periodically, thereby achieving the purpose of treatment.
The above-mentioned embodiments are only intended to describe the preferred embodiments of the present invention, but not to limit the scope of the present invention, and those skilled in the art should also be able to make various modifications and improvements to the technical solution of the present invention without departing from the spirit of the present invention, and all such modifications and improvements are intended to fall within the scope of the present invention as defined in the appended claims.

Claims (8)

1. A novel brain dosing device is characterized in that: the infusion apparatus comprises a medicine bag sleeve (1), a base (2) and an infusion tube (4), wherein a medicine discharging cavity (201) is formed in the upper surface of the base (2), a medicine feeding cavity (101) matched with the base (2) is formed in the lower surface of the medicine bag sleeve (1), and the medicine feeding cavity (101) and the medicine discharging cavity (201) form a medicine bag; the side of base (2) is provided with output tube (202), output tube (202) with transfer line (4) are connected, the distal end of transfer line (4) is the cecum, be provided with several infusion hole (401) on transfer line (4) distal end global.
2. The novel brain drug delivery device according to claim 1, characterized in that: the vertical section of the medicine bag sleeve (1) is trapezoidal, and a groove (102) is formed in the top end of the medicine bag sleeve (1).
3. The novel brain drug delivery device according to claim 1, characterized in that: the medicine bag sleeve (1) is made of medical silica gel.
4. The novel brain drug delivery device according to claim 3, characterized in that: the outer surface of the medicine bag sleeve (1) is provided with a nylon grid (3).
5. The novel brain drug delivery device according to claim 1, characterized in that: the base (2) is made of polyethylene, and the output pipe (202) and the base (2) are integrally formed.
6. The novel brain drug delivery device according to claim 1, characterized in that: the output tube (202) is provided with a connector (203), and the output tube (202) is detachably connected with the near end of the infusion tube (4) through the connector (203).
7. The novel brain drug delivery device according to claim 1, characterized in that: the infusion tube (4) is made of medical silica gel.
8. The novel brain drug delivery device according to claim 1, characterized in that: the cross sections of the medicine bag sleeve (1) and the base (2) are both circular.
CN202220139162.3U 2022-01-19 2022-01-19 Novel brain is dosed device Active CN217067399U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202220139162.3U CN217067399U (en) 2022-01-19 2022-01-19 Novel brain is dosed device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202220139162.3U CN217067399U (en) 2022-01-19 2022-01-19 Novel brain is dosed device

Publications (1)

Publication Number Publication Date
CN217067399U true CN217067399U (en) 2022-07-29

Family

ID=82543166

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202220139162.3U Active CN217067399U (en) 2022-01-19 2022-01-19 Novel brain is dosed device

Country Status (1)

Country Link
CN (1) CN217067399U (en)

Similar Documents

Publication Publication Date Title
US10758668B2 (en) Implantable solid-liquid drug delivery apparatus, formulations, and methods of use
EP2749306B1 (en) Disposable array-type micro injection needle head and pre-filling injector thereof
US7625354B2 (en) Handpiece for fluid administration apparatus
US9572928B2 (en) Substance delivery devices, systems and methods
US20080281265A1 (en) Handpiece For Fluid Administration Apparatus
CN101999956A (en) Implantable intraocular quantitative medicine injection pump
CN110787339A (en) Prevent venous return and keep somewhere needle
CN217067399U (en) Novel brain is dosed device
CN207640751U (en) A kind of department of anesthesia of hospital operation local anaesthesia syringe
CN214859934U (en) Infusion pipeline assembly and infusion device assembly
CN202061177U (en) Hypodermic implantation type drug administration device
CN115569269A (en) Injection needle for transcranial bone marrow and using method thereof
CN213822965U (en) Make things convenient for accurate control's liver cancer to intervene nursing with device of dosing
CN220276125U (en) Anesthetic individuation dosing device
CN219332777U (en) Precise filtering transfusion device with soft needle
CN211357185U (en) Local anesthesia injection needle for anesthesia department
CN215821106U (en) Lumbar puncture needle applied to baby
CN212729926U (en) Puncture tool for nerve block anesthesia
CN219557656U (en) Intranasal administration device of target non-human primate nervous system
CN219963612U (en) Painless diagnosis and treatment drug delivery system
CN215083127U (en) Novel automatic enemator
CN208114631U (en) A kind of Medical anesthetic needle
CN214911512U (en) Disposable low-pressure enemator
CN102151346A (en) Hypodermic implantation type medicine feeder
RU215537U1 (en) SINGLE-USE SYRINGE FOR PACKAGING, STORAGE, TRANSPORTATION AND BOLUS ADMINISTRATION OF BLOOD SUBSTITUTE DRUGS

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant